IBT
HCM icon

International Biotechnology Trust’s HUTCHMED HCM Stock Holding History

International Biotechnology Trust’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-68,000
Closed -$816K – 67
2023
Q2 		$816K Hold
68,000
– – 0.25% 51
2023
Q1 		$885K Hold
68,000
– – 0.25% 54
2022
Q4 		$1M Hold
68,000
– – 0.31% 51
2022
Q3 		$602K Buy
68,000
+67,141
+7,816% +$845K 0.19% 59
2022
Q2 		$68K Sell
859
-67,141
-99% -$855K 0.71% 32
2022
Q1 		$10.1M Hold
68,000
– – 2.27% 17
2021
Q4 		$2.38M Hold
68,000
– – 0.53% 41
2021
Q3 		$2.48M Hold
68,000
– – 0.6% 37
2021
Q2 		$2.67M Buy
+68,000
New +$1.96M 0.71% 33

Other funds holding HCM

MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
AIA Group Hong Kong $7.95B AUM 28.94% 1-Year Est. Return

International Biotechnology Trust's HCM Position: Q3 2023 in Review

International Biotechnology Trust sold out of HUTCHMED (HCM) in Q3 2023, closing a stake of 68,000 shares — an estimated $816K sold.

International Biotechnology Trust first reported a position in HCM in Q2 2021 and held it in 9 quarters. The position peaked at $10.1M in Q1 2022. 65 funds tracked by Wall St. Rank hold HCM as of Q3 2023.

  • International Biotechnology Trust reported no remaining HUTCHMED position as of Q3 2023 after selling out during the quarter.
  • International Biotechnology Trust sold 68,000 HUTCHMED shares in Q3 2023, an estimated $816K.
  • International Biotechnology Trust first reported a position in HUTCHMED in Q2 2021 and held it in 9 quarters.
  • International Biotechnology Trust's HUTCHMED position peaked at $10.1M in Q1 2022.
  • 65 funds tracked by Wall St. Rank held HUTCHMED as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.